Emergent BioSolutions (EBS) Non-Current Assets (2010 - 2026)
Emergent BioSolutions' Non-Current Assets was $450.8 million in Q2 2026, down 35.4% from $697.6 million a year earlier and down 34.0% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Emergent BioSolutions came in at $656.1 million, down 17.1% from FY2024.
- Non-Current Assets has now declined for three consecutive years, with a five-year compound annual growth rate of -17.2% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $791 million in FY2024 (-30.8%), $1.14 billion in FY2023 (-41.5%), $1.96 billion in FY2022 (+15.9%) and $1.69 billion in FY2021 (unchanged).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q4 2013.
- Compared with a year earlier, Non-Current Assets has declined for 13 straight quarters, with an average decline of 23.8% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q4 2022 (growth of 15.9%); the worst was Q4 2023 (a decline of 41.5%).
- Per Business Quant data, EBS's Non-Current Assets in the three quarters before Q2 2026 was $682.8 million (Q1 2026), $656.1 million (Q4 2025) and $674.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.85 Bn | 1,106.43 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 618.85 Bn | 537.37 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 503.03 Bn | 476.14 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 368.52 Bn | 322.90 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 298.19 Bn | 262.18 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 237.14 Bn | 192.53 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 191.35 Bn | 165.54 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 169.80 Bn | 116.45 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Emergent BioSolutions | 320.18 Mn | -430.72 Mn | 137.20 Mn | 450.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 450.80 Mn |
| Mar 31, 2026 | 682.80 Mn |
| Dec 31, 2025 | 656.10 Mn |
| Sep 30, 2025 | 674.10 Mn |
| Jun 30, 2025 | 697.60 Mn |
| Mar 31, 2025 | 719.30 Mn |
| Dec 31, 2024 | 791.00 Mn |
| Sep 30, 2024 | 816.40 Mn |
| Jun 30, 2024 | 859.00 Mn |
| Mar 31, 2024 | 1.12 Bn |
| Dec 31, 2023 | 1.14 Bn |
| Sep 30, 2023 | 1.17 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.73 Bn |
| Dec 31, 2022 | 1.96 Bn |
| Sep 30, 2022 | 1.80 Bn |
| Jun 30, 2022 | 1.65 Bn |
| Mar 31, 2022 | 1.68 Bn |
| Dec 31, 2021 | 1.69 Bn |
| Sep 30, 2021 | 1.76 Bn |
API Access
Emergent BioSolutions Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();